{
  "company_number": "03844664",
  "name": "Pyramid Pharma Pharmaceuticals Limited",
  "url": "/company/03844664",
  "status": "Active",
  "is_active": true,
  "company_type": "Private Limited Company",
  "incorporated_on": "1999-09-20",
  "dissolved_on": null,
  "sic_codes": [
    {
      "code": "47730",
      "description": "Dispensing chemist in specialised stores",
      "section": "G",
      "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles",
      "url": "/sic/47730"
    }
  ],
  "registered_address": {
    "id": 1837751,
    "url": "/address/1837751",
    "line1": "45 GOLDERS GREEN ROAD",
    "line2": "",
    "post_town": "LONDON",
    "county": "",
    "country": "ENGLAND",
    "postcode": "NW11 8EL"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/03844664",
  "previous_names": [],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "United Kingdom",
  "accounts": {
    "next_due": "2027-01-31",
    "last_made_up": "2025-04-30",
    "category": "TOTAL EXEMPTION FULL",
    "filings": [
      {
        "url": "/company/03844664/accounts/2025-04-30",
        "pdf_url": "/company/03844664/accounts/2025-04-30.pdf",
        "made_up_date": "2025-04-30",
        "period_start": "2025-04-30",
        "period_end": "2025-04-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": false,
        "average_employees": "9.00",
        "tangible_fixed_assets": "3249967.00",
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": "7666315.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "5192316.00",
        "total_assets_less_current_liabilities": "8442283.00",
        "net_assets_liabilities": "7191560.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "7191560.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2026.zip"
      },
      {
        "url": "/company/03844664/accounts/2024-04-30",
        "pdf_url": "/company/03844664/accounts/2024-04-30.pdf",
        "made_up_date": "2024-04-30",
        "period_start": "2024-04-30",
        "period_end": "2024-04-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": false,
        "average_employees": "98.00",
        "tangible_fixed_assets": "3249967.00",
        "debtors": "6612093.00",
        "cash_bank_in_hand": "269733.00",
        "current_assets": "7666315.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "5192316.00",
        "total_assets_less_current_liabilities": "8442283.00",
        "net_assets_liabilities": "7191560.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "6.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2025.zip"
      },
      {
        "url": "/company/03844664/accounts/2023-04-30",
        "pdf_url": "/company/03844664/accounts/2023-04-30.pdf",
        "made_up_date": "2023-04-30",
        "period_start": "2023-04-30",
        "period_end": "2023-04-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": false,
        "average_employees": "96.00",
        "tangible_fixed_assets": "2804972.00",
        "debtors": "4647542.00",
        "cash_bank_in_hand": "389755.00",
        "current_assets": "5765693.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "4875069.00",
        "total_assets_less_current_liabilities": "7680041.00",
        "net_assets_liabilities": "6248011.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "6.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2024.zip"
      },
      {
        "url": "/company/03844664/accounts/2022-04-30",
        "pdf_url": "/company/03844664/accounts/2022-04-30.pdf",
        "made_up_date": "2022-04-30",
        "period_start": "2022-04-30",
        "period_end": "2022-04-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": false,
        "average_employees": "9.00",
        "tangible_fixed_assets": "3953624.00",
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": "3094920.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "2551098.00",
        "total_assets_less_current_liabilities": "6504722.00",
        "net_assets_liabilities": "5251472.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "5251472.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2023.zip"
      },
      {
        "url": "/company/03844664/accounts/2021-04-30",
        "pdf_url": "/company/03844664/accounts/2021-04-30.pdf",
        "made_up_date": "2021-04-30",
        "period_start": "2021-04-30",
        "period_end": "2021-04-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": false,
        "average_employees": "9.00",
        "tangible_fixed_assets": "3953624.00",
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": "3094920.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "2551098.00",
        "total_assets_less_current_liabilities": "6504722.00",
        "net_assets_liabilities": "5251472.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "5251472.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2022.zip"
      },
      {
        "url": "/company/03844664/accounts/2020-04-30",
        "pdf_url": "/company/03844664/accounts/2020-04-30.pdf",
        "made_up_date": "2020-04-30",
        "period_start": "2020-04-30",
        "period_end": "2020-04-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": false,
        "average_employees": "74.00",
        "tangible_fixed_assets": "3321641.00",
        "debtors": "1982132.00",
        "cash_bank_in_hand": "295709.00",
        "current_assets": "2773155.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "2248408.00",
        "total_assets_less_current_liabilities": "5570049.00",
        "net_assets_liabilities": "4304344.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "6.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2021.zip"
      },
      {
        "url": "/company/03844664/accounts/2019-04-30",
        "pdf_url": "/company/03844664/accounts/2019-04-30.pdf",
        "made_up_date": "2019-04-30",
        "period_start": "2019-04-30",
        "period_end": "2019-04-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": false,
        "average_employees": "61.00",
        "tangible_fixed_assets": "2904865.00",
        "debtors": "1429661.00",
        "cash_bank_in_hand": "627163.00",
        "current_assets": "2553636.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "2035952.00",
        "total_assets_less_current_liabilities": "4940817.00",
        "net_assets_liabilities": "4006744.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "6.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2020.zip"
      },
      {
        "url": "/company/03844664/accounts/2018-04-30",
        "pdf_url": "/company/03844664/accounts/2018-04-30.pdf",
        "made_up_date": "2018-04-30",
        "period_start": "2018-04-30",
        "period_end": "2018-04-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": false,
        "average_employees": "48.00",
        "tangible_fixed_assets": "3672854.00",
        "debtors": "701730.00",
        "cash_bank_in_hand": "468.00",
        "current_assets": "1335204.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "159248.00",
        "total_assets_less_current_liabilities": "3832102.00",
        "net_assets_liabilities": "2698488.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "6.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2019.zip"
      },
      {
        "url": "/company/03844664/accounts/2017-04-30",
        "pdf_url": "/company/03844664/accounts/2017-04-30.pdf",
        "made_up_date": "2017-04-30",
        "period_start": "2017-04-30",
        "period_end": "2017-04-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": false,
        "average_employees": "45.00",
        "tangible_fixed_assets": "2830796.00",
        "debtors": "561329.00",
        "cash_bank_in_hand": "790762.00",
        "current_assets": "1844478.00",
        "creditors_due_within_one_year": "993235.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "851243.00",
        "total_assets_less_current_liabilities": "3682039.00",
        "net_assets_liabilities": "2607163.00",
        "called_up_share_capital": "6.00",
        "profit_loss_account_reserve": "1606673.00",
        "shareholder_funds": "6.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-February2018.zip"
      },
      {
        "url": "/company/03844664/accounts/2016-04-30",
        "pdf_url": "/company/03844664/accounts/2016-04-30.pdf",
        "made_up_date": "2016-04-30",
        "period_start": "2016-04-30",
        "period_end": "2016-04-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "2103221.00",
        "debtors": "568452.00",
        "cash_bank_in_hand": "55941.00",
        "current_assets": "1094468.00",
        "creditors_due_within_one_year": "812976.00",
        "creditors_due_after_one_year": "539483.00",
        "net_current_assets_liabilities": "281492.00",
        "total_assets_less_current_liabilities": "2384713.00",
        "net_assets_liabilities": "1845230.00",
        "called_up_share_capital": "6.00",
        "profit_loss_account_reserve": "844740.00",
        "shareholder_funds": "1845230.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2017.zip"
      },
      {
        "url": "/company/03844664/accounts/2015-04-30",
        "pdf_url": "/company/03844664/accounts/2015-04-30.pdf",
        "made_up_date": "2015-04-30",
        "period_start": "2015-04-30",
        "period_end": "2015-04-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "1651837.00",
        "debtors": "451260.00",
        "cash_bank_in_hand": "468.00",
        "current_assets": "920312.00",
        "creditors_due_within_one_year": "914459.00",
        "creditors_due_after_one_year": "137647.00",
        "net_current_assets_liabilities": "5853.00",
        "total_assets_less_current_liabilities": "1657690.00",
        "net_assets_liabilities": "1520043.00",
        "called_up_share_capital": "6.00",
        "profit_loss_account_reserve": "519553.00",
        "shareholder_funds": "1520043.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2016.zip"
      },
      {
        "url": "/company/03844664/accounts/2014-04-30",
        "pdf_url": "/company/03844664/accounts/2014-04-30.pdf",
        "made_up_date": "2014-04-30",
        "period_start": "2014-04-30",
        "period_end": "2014-04-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "1652598.00",
        "debtors": "335145.00",
        "cash_bank_in_hand": "468.00",
        "current_assets": "805066.00",
        "creditors_due_within_one_year": "845251.00",
        "creditors_due_after_one_year": "153973.00",
        "net_current_assets_liabilities": "-40185.00",
        "total_assets_less_current_liabilities": "1612413.00",
        "net_assets_liabilities": "1458440.00",
        "called_up_share_capital": "6.00",
        "profit_loss_account_reserve": "457950.00",
        "shareholder_funds": "1458440.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2015.zip"
      },
      {
        "url": "/company/03844664/accounts/2013-04-30",
        "pdf_url": "/company/03844664/accounts/2013-04-30.pdf",
        "made_up_date": "2013-04-30",
        "period_start": "2013-04-30",
        "period_end": "2013-04-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "1592945.00",
        "debtors": "140202.00",
        "cash_bank_in_hand": "468.00",
        "current_assets": "582030.00",
        "creditors_due_within_one_year": "922264.00",
        "creditors_due_after_one_year": "182959.00",
        "net_current_assets_liabilities": "-340234.00",
        "total_assets_less_current_liabilities": "1252711.00",
        "net_assets_liabilities": "1069752.00",
        "called_up_share_capital": "6.00",
        "profit_loss_account_reserve": "69262.00",
        "shareholder_funds": "1069752.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2014.zip"
      },
      {
        "url": "/company/03844664/accounts/2012-04-30",
        "pdf_url": "/company/03844664/accounts/2012-04-30.pdf",
        "made_up_date": "2012-04-30",
        "period_start": "2012-04-30",
        "period_end": "2012-04-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "1136315.00",
        "debtors": "272462.00",
        "cash_bank_in_hand": "468.00",
        "current_assets": "414382.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-5687.00",
        "total_assets_less_current_liabilities": "1130628.00",
        "net_assets_liabilities": "1040149.00",
        "called_up_share_capital": "6.00",
        "profit_loss_account_reserve": "39659.00",
        "shareholder_funds": "1040149.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "xml",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2012.zip"
      },
      {
        "url": "/company/03844664/accounts/2011-04-30",
        "pdf_url": "/company/03844664/accounts/2011-04-30.pdf",
        "made_up_date": "2011-04-30",
        "period_start": "2011-04-30",
        "period_end": "2011-04-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "686250.00",
        "debtors": "259967.00",
        "cash_bank_in_hand": "468.00",
        "current_assets": "411637.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-97099.00",
        "total_assets_less_current_liabilities": "589151.00",
        "net_assets_liabilities": "589151.00",
        "called_up_share_capital": "6.00",
        "profit_loss_account_reserve": "18661.00",
        "shareholder_funds": "589151.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "xml",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2012.zip"
      },
      {
        "url": "/company/03844664/accounts/2010-04-30",
        "pdf_url": "/company/03844664/accounts/2010-04-30.pdf",
        "made_up_date": "2010-04-30",
        "period_start": "2010-04-30",
        "period_end": "2010-04-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": true,
        "average_employees": null,
        "tangible_fixed_assets": null,
        "debtors": null,
        "cash_bank_in_hand": "1.00",
        "current_assets": null,
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": null,
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "1.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-June2011.zip"
      },
      {
        "url": "/company/03844664/accounts/2009-09-30",
        "pdf_url": "/company/03844664/accounts/2009-09-30.pdf",
        "made_up_date": "2009-09-30",
        "period_start": "2009-09-30",
        "period_end": "2009-09-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": true,
        "average_employees": null,
        "tangible_fixed_assets": null,
        "debtors": null,
        "cash_bank_in_hand": "1.00",
        "current_assets": null,
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": null,
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "1.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "xml",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-July2010.zip"
      },
      {
        "url": "/company/03844664/accounts/2008-09-30",
        "pdf_url": "/company/03844664/accounts/2008-09-30.pdf",
        "made_up_date": "2008-09-30",
        "period_start": "2008-09-30",
        "period_end": "2008-09-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": true,
        "average_employees": null,
        "tangible_fixed_assets": null,
        "debtors": null,
        "cash_bank_in_hand": "1.00",
        "current_assets": null,
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": null,
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "1.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "xml",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-JanuaryToDecember2009.zip"
      },
      {
        "url": "/company/03844664/accounts/2007-09-30",
        "pdf_url": "/company/03844664/accounts/2007-09-30.pdf",
        "made_up_date": "2007-09-30",
        "period_start": "2007-09-30",
        "period_end": "2007-09-30",
        "entity_name": "Pyramid Pharma Pharmaceuticals Limited",
        "dormant": true,
        "average_employees": null,
        "tangible_fixed_assets": null,
        "debtors": null,
        "cash_bank_in_hand": "1.00",
        "current_assets": null,
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": null,
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "1.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "xml",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-JanuaryToDecember2008.zip"
      }
    ],
    "pdf_only_filings": [
      {
        "made_up_date": "2006-09-30",
        "filing_date": "2007-08-22",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-dormant",
        "paper_filed": null,
        "pdf_url": "/company/03844664/accounts/2006-09-30.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/03844664/filing-history/MTg0Mzg2NjEwYWRpcXprY3g/document?format=pdf&download=0"
      },
      {
        "made_up_date": "2005-09-30",
        "filing_date": "2006-03-30",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-dormant",
        "paper_filed": true,
        "pdf_url": "/company/03844664/accounts/2005-09-30.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/03844664/filing-history/MTU4NDI1MzU2YWRpcXprY3g/document?format=pdf&download=0"
      },
      {
        "made_up_date": "2004-09-30",
        "filing_date": "2005-08-31",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-dormant",
        "paper_filed": true,
        "pdf_url": "/company/03844664/accounts/2004-09-30.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/03844664/filing-history/NjE4ODQwNDhhZGlxemtjeA/document?format=pdf&download=0"
      },
      {
        "made_up_date": "2003-09-30",
        "filing_date": "2004-04-21",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-dormant",
        "paper_filed": true,
        "pdf_url": "/company/03844664/accounts/2003-09-30.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/03844664/filing-history/MTgzMjk4NDBhZGlxemtjeA/document?format=pdf&download=0"
      },
      {
        "made_up_date": "2002-09-30",
        "filing_date": "2003-07-14",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-dormant",
        "paper_filed": true,
        "pdf_url": "/company/03844664/accounts/2002-09-30.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/03844664/filing-history/MjQ4OTk1NDVhZGlxemtjeA/document?format=pdf&download=0"
      },
      {
        "made_up_date": "2001-09-30",
        "filing_date": "2002-03-22",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-dormant",
        "paper_filed": true,
        "pdf_url": "/company/03844664/accounts/2001-09-30.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/03844664/filing-history/OTcyMjk3NzFhZGlxemtjeA/document?format=pdf&download=0"
      },
      {
        "made_up_date": "2000-09-30",
        "filing_date": "2001-07-25",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-dormant",
        "paper_filed": true,
        "pdf_url": "/company/03844664/accounts/2000-09-30.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/03844664/filing-history/NDMzNDc5ODhhZGlxemtjeA/document?format=pdf&download=0"
      }
    ],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/03844664/filing-history"
  },
  "confirmation_statement": {
    "next_due": "2027-02-09",
    "last_made_up": "2026-01-26"
  },
  "officers": [],
  "psc": [
    {
      "name": "Mr Amir Singh Bhogal",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/291099",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent",
        "voting-rights-25-to-50-percent",
        "right-to-appoint-and-remove-directors"
      ],
      "notified_on": "2023-12-01",
      "ceased_on": null,
      "nationality": "British",
      "country_of_residence": "England",
      "source": "snapshot"
    },
    {
      "name": "Mr Kabir Singh Bhogal",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/2554519",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent",
        "voting-rights-25-to-50-percent",
        "right-to-appoint-and-remove-directors"
      ],
      "notified_on": "2016-05-01",
      "ceased_on": null,
      "nationality": "British",
      "country_of_residence": "United Kingdom",
      "source": "snapshot"
    }
  ],
  "external_links": [],
  "provenance": {
    "source": "snapshot",
    "first_seen_at": "2026-07-05T12:35:35.811816+00:00",
    "last_seen_snapshot": "2026-09-01",
    "retrieved_at": "2026-09-13T04:27:19.630781+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}